Half-year summary of NATUREX's liquidity contract December 2013
Half-year summary of NATUREX's
liquidity contract with EXANE BNP PARIBAS
Press release
Avignon, 31 January 2014
Pursuant to the liquidity contract granted to EXANE BNP PARIBAS regarding NATUREX shares, the following elements were in the liquidity account as of December 31st, 2013, settlement date:
- 8,642 NATUREX shares
- 269,721.00 euros
It is reminded that at the start of the operations in August 2013, the following assets appeared on the liquidity account :
- 7,154 NATUREX shares
- 346,979.00 euros
If you would like to receive financial information about Naturex by e-mail, go to: www.naturex.com
Naturex has been listed on NYSE Euronext Paris, Compartment B (MidCaps), since October 1996.
Total number of shares comprising the share capital: 7,843,251
ISIN FR0000054694
Naturex is a component of the CAC Small and Gaïa indexes.
Naturex is eligible for "long only" Deferred Settlement Service (SRD).
Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.
SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY
About Naturex
NATUREX is the global leader in specialty plant-based natural ingredients.The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
NATUREX's head office is based in Avignon. The company employs more than 1,400 people and benefits from 8 sourcing offices around the world and high-performance manufacturing operations across 15 sites in Europe, in Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.
| Contacts | |
| Thierry Lambert Chairman and Chief Executive Officer Tel: +33 (0)4 90 23 96 89 [email protected] |
Thierry Bertrand Lambert Chief Financial Officer Tel: +33 (0)4 90 23 96 89 [email protected] |
|
Carole Alexandre Investor Relations Tel: +33 (0)4 90 23 78 28 [email protected] |
Anne Catherine Bonjour Actus Finance Press Relations Tel: +33 (0)1 53 67 36 93 [email protected] |
Rachat d'actions / contrat de liquidité :
- Information relative au contrat de liquidité
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-34761-2014.01.31-half-year-summary-of-naturex_s-liquidity-contract_december-2013.pdf
© Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
Quelle: Actusnews
